<?xml version="1.0" encoding="ISO-8859-1"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bp="http://www.biopax.org/release/biopax-level2.owl#" xmlns="http://www.phidias.us/biopax#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:daml="http://www.daml.org/2001/03/daml+oil#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <owl:Ontology rdf:about="">
    <owl:imports rdf:resource="http://www.biopax.org/release/biopax-level2.owl"/>
  </owl:Ontology>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Enzyme">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Eukaryotic_cell_or_cell_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eukaryotic cell or cell component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Microbe-host_cell_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Microbe-host cell complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Microorganism_or_its_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Microorganism or its component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Other_--_ion">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other -- ion</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Pathway_or_action">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway or action</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_gene">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or gene</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_gene_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or gene complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_type_Protein_or_protein_complex">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Protein or protein complex</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Bacterial_membrane_or_virus_envelope">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bacterial membrane or virus envelope</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Cytoplasm">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cytoplasm</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Eukaryotic_cell_or_cell_component">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eukaryotic cell or cell component</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Extracellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Extracellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Golgi">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golgi</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Golgi_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Golgi membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Intercellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intercellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Intracellular">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Intracellular</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Mitochondria">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mitochondria</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Nucleocapsid/Cytoplasm">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleocapsid/Cytoplasm</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Cell_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Cell membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Endoplasmic_reticulum">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Endoplasmic reticulum</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_ER">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- ER</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Golgi">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Golgi</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Golgi_membrane">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Golgi membrane</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Nucleus">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Nucleus</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Phagolysosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Phagolysosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Phagosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Phagosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Organelle_--_Ribosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Organelle -- Ribosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Phagolysosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phagolysosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_location_Phagosome">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phagosome</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Chaperone">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chaperone</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Defense,_immunity_protein">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Defense, immunity protein</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme_activator">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme activator</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Enzyme_inhibitor">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enzyme inhibitor</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Genomic_S_segment">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genomic S segment</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Infection">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Infection</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Ligand_binding_or_carrier">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ligand binding or carrier</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Motor">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Motor</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Nucleic_acid_binding">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nucleic acid binding</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Other">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Other</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Signal_transducer">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Signal transducer</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Toxicity">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Toxicity</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transcription_factor_binding">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transcription factor binding</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transcription_regulation">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transcription regulation</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Transporter">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Transporter</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:openControlledVocabulary rdf:ID="vocabulary_bioobject_function_Unknown">
    <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Unknown</bp:TERM>
  </bp:openControlledVocabulary>
  <bp:evidence rdf:ID="evidence_IC">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IC">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IC</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred by Curator</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IDA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IDA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IDA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Direct Assay</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IEA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IEA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IEA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Electronic Annotation</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IEP">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IEP">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IEP</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Expression Pattern</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IGI">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IGI">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IGI</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Genetic Interaction</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IMP">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IMP">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IMP</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Mutant Phenotype</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_IPI">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_IPI">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">IPI</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Physical Interaction</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_ISS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_ISS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ISS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Inferred from Sequence or Structural Similarity</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_NAS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_NAS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NAS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Non-traceable Author Statement</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_ND">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_ND">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ND</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">No biological Data available</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_RCA">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_RCA">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">RCA</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">inferred from Reviewed Computational Analysis</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_TAS">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_TAS">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">TAS</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Traceable Author Statement</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:evidence rdf:ID="evidence_NR">
    <bp:EVIDENCE-CODE>
      <bp:openControlledVocabulary rdf:ID="vocabulary_go_evidence_NR">
        <bp:TERM rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NR</bp:TERM>
        <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Not Recorded</bp:COMMENT>
      </bp:openControlledVocabulary>
    </bp:EVIDENCE-CODE>
  </bp:evidence>
  <bp:publicationXref rdf:ID="reference5299">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of experimental medicine</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">20024</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11877482</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5300">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chan SY, Ma MC, Goldsmith MA</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of general virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2000</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10950971</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5301">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Volchkov VE</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marburg and Ebola viruses</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Processing of infectious Ebola virus glycoprotein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5294">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jeffers SA, Sanders DA, Sanchez A</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Covalent modifications of the ebola virus glycoprotein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12438572</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5297">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Modrof J, Becker S, Muhlberger E</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ebola virus transcription activator VP30 is a zinc-binding protein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12584359</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5298">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Han Z, Boshra H, Sunyer JO, Zwiers SH, Paragas J, Harty RN</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Journal of virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2003</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12525613</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5285">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huang Y, Xu L, Sun Y, Nabel GJ</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular cell</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12191476</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5302">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Feldmann H and Kiley MP</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marburg and Ebola viruses</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Classification, structure, and replication of filoviruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5305">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peters CJ, Sanchez A, Rollin PE, Ksiazek TG, and Murphy FA</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Field's Virology Third Edition Volume 1</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Filoviridae:  Marburg and Ebola Viruses</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">1999</bp:YEAR>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5296">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bray M, Paragas J</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antiviral research</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Experimental therapy of filovirus infections</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2002</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11888653</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:publicationXref rdf:ID="reference5282">
    <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Feldmann H, Volchkov VE, Volchkova VA, Stroher U, Klenk HD</bp:AUTHORS>
    <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of general virology</bp:SOURCE>
    <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biosynthesis and role of filoviral glycoproteins</bp:TITLE>
    <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#int">2001</bp:YEAR>
    <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11714958</bp:ID>
    <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
  </bp:publicationXref>

  <bp:physicalEntityParticipant rdf:ID="bioobject_198">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Ligand binding or carrier.
Cell entry is presumably mediated by GP (Feldmann and Kiley, 1999).  Each molecule in the trimeric GP is composed of an external segment, GP1, which is linked by a disulfide bond to a transmembrane unit, GP2 (Bray and Paragas, 2002).  Several groups have demonstrated independently that the transmembrane glycoprotein of filoviruses mediates receptor binding and subsequent fusion with susceptible cells (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_199">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell membrane receptor</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Ligand binding or carrier.
There is evidence that Marburg virus uses the asialoglycoprotein receptor to infect hepatocytes.  For Ebola virus, it was suggested that integrins, especially the Beta1 group, might interact with the glycoprotein and perhaps be involved in entry into the cells.  More recent studies indicate that the folate receptor-alpha serves as a cofactor for cellular entry by Marburg and Ebola viruses (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_200">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Attached virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Replication begins with the attachment of the virion to a cell-surface receptor, which may be the alpha-folate receptor.  After binding, the virus enters the cell through receptor-mediated endocytosis  (Bray and Paragas, 2002).(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_201">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fused virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Fusion of the viral envelope with the cellular endosomal membrane releases the RNP into the cytoplasm  (Bray and Paragas, 2002).  Fusion activity has never been demonstrated experimentally.  Early post-infection filovirus particles are associated with coated pits along the plasma membrane, indicating endocytosis as a possible mechanism for entry.  This observation, together with mutational analysis of the putative fusion domain, offers compelling support for a role for the conserved hydrophobic region in the Ebola virus transmembrane glycoprotein GP as a fusion peptide (Feldmann et al., 2001).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_202">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Uncoated virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virus entry is probably receptor-mediated followed by fusion and uncoating, two steps which have not yet been examined (Feldmann and Kiley, 1999).(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_203">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">L protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
Two other proteins present in lower copy number within the virion, VP35 and the RNA-dependent RNA polymerase, or L protein, associate with VP30 and NP to make up the Ebola replication complex (Bray and Paragas, 2002).  The RNA-dependent RNA polymerase or L protein is the largest and least abundant viral protein in both the virion and in infected cells (Peters et al., 1996).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5305">Peters</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_204">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Replication complex</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The ribonucleoprotein (RNP) complex in the virion core, made up of the RNA genome and its encapsidating proteins, VP30 and NP, is linked by matrix proteins to the glycoprotein (GP)-bearing lipid envelope derived from the host cell membrane (Bray and Paragas, 2002).  Two other proteins present in lower copy number within the virion, VP35 and the RNA-dependent RNA polymerase, or L protein, associate with VP30 and NP to make up the Ebola replication complex (Bray and Paragas, 2002). Genomes of filoviruses consist of a single negative-stranded linear RNA molecule.  The RNA is noninfectious, does not contain a poly(A) tail, and upon entry into the cytoplasm of host cells is transcribed to generated polyadenylated subgenomic mRNA species (Feldmann and Kiley, 1999).  Filovirus transcription and replication take place in the cytoplasm of infected cells (Feldmann and Kiley, 1999).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_205">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Negative sense genome</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Genomes of filoviruses consist of a single negative-stranded linear RNA molecule.  The RNA is noninfectious, does not contain a poly(A) tail, and upon entry into the cytoplasm of host cells is transcribed to generated polyadenylated subgenomic mRNA species (Feldmann and Kiley, 1999).  Filovirus transcription and replication take place in the cytoplasm of infected cells (Feldmann and Kiley, 1999).(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_206">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NP mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).  The nucleoprotein (NP) is encoded by gene 1 at the extreme 3' end of the linear unsegmented RNA genome (Feldmann and Kiley, 1999).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_207">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP35 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).  Virion structural protein 35 (VP35) is encoded by gene 2 (Feldmann and Kiley, 1999).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_208">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP40 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virion structural protein 40 (VP40) of filoviruses is encoded by gene 3 (Feldmann and Kiley, 1999).(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_209">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Glycoprotein (GP), encoded by gene 4 of the genome, is the only glycosylated structural protein of virions (Feldmann and Kiley, 1999).  The GP is the sole structural protein that makes up the virion surface spikes that mediate virus entry into susceptible host cells through receptor binding (Peters et al., 1996).(<a href="#reference5302">Feldmann2</a>)(<a href="#reference5305">Peters</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_210">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sGP mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Filoviral glycoproteins are encoded by gene 4 (GP gene) of the non-segmented, negative-stranded RNA genome  (Feldmann and Kiley, 1999).  In the case of Ebola, but not Marburg virus, the primary product encoded by the GP gene is a truncated protein lacking a C-terminal hydrophobic membrane anchor. This `soluble GP' (sGP) is released from infected cells  (Bray and Paragas, 2002).(<a href="#reference5302">Feldmann2</a>)(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_211">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP30 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virion structural protein 30 (VP30) is encoded by gene 5 of filoviruses and is intimately associated with the RNP complex (Feldmann and Kiley, 1999).(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_212">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP24 mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Virion structural protein 24 (VP24) is encoded by gene 6 of filoviruses (Feldmann and Kiley, 1999).  Recent studies have demonstrated that cotransfection of 293T cells with NP, VP35, and VP24 supported capsid formation, and omission of any one of these three genes abolished the effect, demonstrating that they are necessary and sufficient for viral particle formation (Huang et al., 2002).(<a href="#reference5302">Feldmann2</a>)(<a href="#reference5285">Huang et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_213">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">L mRNA</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The large (L) protein is encoded at the 5' end of the linear genome (Feldmann and Kiley, 1999).(<a href="#reference5302">Feldmann2</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_214">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Positive sense genome</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_215">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Negative sense genome</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_216">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).NP is the primary structural protein associates with filovirus nucleocapsids (Peters et al., 1996).  Recent studies have demonstrated that cotransfection of 293T cells with NP, VP35, and VP24 supported capsid formation, and omission of any one of these three genes abolished the effect, demonstrating that they are necessary and sufficient for viral particle formation (Huang et al., 2002).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5305">Peters</a>)(<a href="#reference5285">Huang et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_217">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP35 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Transcription by the viral RNA-dependent RNA polymerase initiates at the 3' end of the genome, resulting in synthesis of a leader RNA and seven polyadenylated mRNAs. Accumulation of the first two proteins encoded at the 3' end of the genome (NP and VP35) in some way triggers a switch to production of full-length, positive-sense `antigenomes', which serve, in turn, as templates for genome synthesis (Bray and Paragas, 2002).Recent studies have demonstrated that cotransfection of 293T cells with NP, VP35, and VP24 supported capsid formation, and omission of any one of these three genes abolished the effect, demonstrating that they are necessary and sufficient for viral particle formation (Huang et al., 2002).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5285">Huang et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_218">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP40 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
VP40 facilitates the formation of hollow tubular membranes that may facilitate the formation of the surrounding envelope, but does not contribute to the generation of the filamentous viral capsid (Huang et al., 2002).  The VP40 protein of Ebola virus is the primary matrix protein and the most abundant virion component (Han et al., 2003).(<a href="#reference5285">Huang et al., 2002</a>)(<a href="#reference5298">Han et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_219">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Glycoprotein (GP) is the only glycosylated structural protein of virions (Feldmann and Kiley, 1999).  The GP is the sole structural protein that makes up the virion surface spikes that mediate virus entry into susceptible host cells through receptor binding (Peters et al., 1996).(<a href="#reference5302">Feldmann2</a>)(<a href="#reference5305">Peters</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_220">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-sGP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
In the case of Ebola, but not Marburg virus, the primary product encoded by the GP gene is a truncated protein lacking a C-terminal hydrophobic membrane anchor. This `soluble GP' (sGP) is released from infected cells  (Bray and Paragas, 2002).(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_221">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP30 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Ebola virus VP30 is an essential activator of viral transcription. In viral particles, VP30 is closely associated with the nucleocapsid complex. A conspicuous structural feature of VP30 is an unconventional zinc-binding Cys(3)-His motif comprising amino acids 68 to 95 (Modrof et al., 2003).(<a href="#reference5297">Modrof et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_222">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">VP24 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The VP24 protein of Ebola virus is believed to be a secondary matrix protein and minor component of virions. In contrast, the VP40 protein of Ebola virus is the primary matrix protein and the most abundant virion component.    VP24 possesses structural features commonly associated with viral matrix proteins and that VP24 may have a role in virus assembly and budding (Han et al., 2003).(<a href="#reference5298">Han et al., 2003</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_223">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">L protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: Enzyme.
The L protein is regarded as an RNA-dependent RNA polymerase (Feldmann and Kiley, 1999).  As with other negative-strand RNA viruses, the RNA-dependent RNA polymerase of L protein of filoviruses is the largest and least abundant viral protein in both the virion and in infected cells (Peters et al., 1996).(<a href="#reference5302">Feldmann2</a>)(<a href="#reference5305">Peters</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_224">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Endoplasmic_reticulum"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
An N-glycosylated precursor form of GP (pre-GP), is found in the endoplasmic reticulum (Jeffers et al., 2002).(<a href="#reference5294">Jeffers et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_225">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-sGP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Endoplasmic_reticulum"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The primary gene product of the Ebola virus GP gene is a secreted GP, cleaved to generate secreted GP (sGP) and delta peptide (Jeffers et al., 2002).  pre-sGP undergoes several co- and post-translational processing events, such as signal peptide cleavage, glycosylation, oligomerization, and proteolytic cleavage.  The limiting step during maturation and transport seems to be oligomerization in the endoplasmic reticulum (Feldmann et al., 2001).(<a href="#reference5294">Jeffers et al., 2002</a>)(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_226">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-GP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
pre-GP is processed to a fully glycosylated uncleaved form, GP0,  in the Golgi apparatus.  Trafficking to the Golgi apparatus also leads to the addition of O-linked glycans (Jeffers et al., 2002).(<a href="#reference5294">Jeffers et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_227">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">pre-sGP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
After oligomerization, pre-sGP is transported into the Golgi compartments where glycosylation is completed and post-translational cleavage into sGP and a small peptide, designated delta peptide, occurs.  Cleavage is mediated by furin (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_228">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
In the trans-Golgi apparatus, GP0 is cleaved by the convertase furin to generate GP1, whose role appears to involve receptor binding, and transmembrane GP2.  These two subunits are linked by disulfide bonding (Jeffers et al., 2002).  GP1 is highly glycosylated with N-linked and O-linked glycans.  Glycosylation contributes approximately half of the mass of GP1, and O-linked glycans confer a mucin-like property to its C terminus (Jeffers et al., 2002).(<a href="#reference5294">Jeffers et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_229">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP2 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
In the trans-Golgi apparatus, GP0 is cleaved by the convertase furin to generate GP1, whose role appears to involve receptor binding, and transmembrane GP2.  These two subunits are linked by disulfide bonding (Jeffers et al., 2002).  GP2 contains a sequence of several, uncharged hydrophobic amino acids at a distance of 22 (Ebola virus) or 91 (Marburg virus) amino acids from the cleavage site and which bears some structural similarity to the fusion peptides of retroviruses (Feldmann et al., 2001).  GP2 also contains N-linked glycans with two predicted N-linked sites but does not appear to contain O-linked glycans (Jeffers et al., 2002).(<a href="#reference5294">Jeffers et al., 2002</a>)(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_230">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Delta peptide</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The small cleavage product of pre-sGP, delta peptide, varies in length between 40 and 48 amino acids for the different Ebola viruses.  Its molecular mass of about 10-14 kDa is significantly larger than the one predicted from the amino acid sequence (about 4.7 kDa).  This difference in size is due to the attachment of several O-glycans that carry terminal sialic acids.  In this respect, it differs from sGP, which seems mainly to carry N-linked carbohydrates (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_231">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sGP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
After oligomerization, pre-sGP is transported into the Golgi compartments where glycosylation is completed and post-translational cleavage into sGP and a small peptide, designated delta peptide, occurs.  Cleavage is mediated by furin, which is also responsible for the cleavage of pre-GP (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_238">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Furin</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
>Furin belongs to the proprotein convertases, a family of subtilisin-like eukaryotic endoproteases.  These enzymes are differentially expressed in cells and tissues, and they display similar by not identical specificity for basic motifs, such as RXK/RR, at the cleavage site of their substrates.  Furin is expressed inmost cells and is localized predominantly in the trans Golgi network.  Furin appears to be the key enzyme in virus activation.  It is also noteworthy that furin, although ubiquitous, is particularly rich in hepatocytes and endothelial cells which are both prime targets of Ebola virus.  These observations stress the importance of furin as a processing enzyme of GP (Volchkov, 1999).  After oligomerization, pre-sGP is transported into the Golgi compartments where glycosylation is completed and post-translational cleavage into sGP and a small peptide, designated delta peptide, occurs.  Cleavage is mediated by furin, which is also responsible for the cleavage of pre-GP (Feldmann et al., 2001).(<a href="#reference5301">Volchkov3</a>)(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_239">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1/2 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Organelle_--_Golgi_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
A special arrangement of cysteine residues in the GP1/2 molecules allows the formation of an intramolecular disulphide bridge between the two cleavage products.  This suggests a stem region consisting of GP1 and GP2 and a crown-like domain on the top formed by GP1 that carries the mass of the carbohydrate side chains.  The mature transmembrane glycoprotein is a trimer comprising disulphide-bonded GP1/2 molecules.  The mature transmembrane glycoprotein forms spikes without the need for other viral proteins (Feldmann et al., 2001).GP1/2 is the virion form of GP and it is also present in cells, presumably in the trans Golgi network and on the cell surface (Volchkov, 1999).(<a href="#reference5282">Feldmann et al., 2001</a>)(<a href="#reference5301">Volchkov3</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_240">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1/2 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The mature envelope glycoprotein GP1/2 is anchored in the membrane by a carboxy-terminal hydrophobic domain of GP2. The middle region of GP1/2 is variable, extremely hydrophilic and carries the bulk of N- and O-glycans, which account for more than one-third of the molecular mass of the mature protein. Oligosaccharide side chains differ in their terminal sialylation patterns. Two carboxy-terminal cysteine residues are acylated. GP2 contains a sequence of several uncharged, hydrophobic amino acids at a distance of 22 (EBOV) or 91 (MBGV) amino acids from the cleavage site and which bears some structural similarity to the fusion peptides of retroviruses.  The special arrangement of the cysteine residues in the GP1/2 molecules allows the formation of an intramolecular disulphide bridge between the two cleavage products. This suggests a stem region consisting of GP1 and GP2 and a crown-like domain on the top formed by GP1 that carries the mass of the carbohydrate side chains. It can be assumed that cysteine residue 53 is also critical for maintaining the structure of GP1/2. The mature transmembrane glycoprotein is a trimer comprising disulphide-bonded GP1/2 molecules (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_241">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GP1 protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
During maturation, GP1 is partly shed in monomeric form after the release of its disulphide linkage to the transmembrane subunit GP2 (Feldmann et al., 2001).  This free GP1 is shed in a nonvirion-bound form and has been hypothesized to be pathogenic (Chan et al., 2000).(<a href="#reference5282">Feldmann et al., 2001</a>)(<a href="#reference5300">Chan et al., 2000</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_242">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Delta peptide</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Delta peptide is secreted from cells but this process seems not to be as efficient as the secretion of sGP (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_243">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">sGP protein</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Due to a lack of a transmembrane anchor, sGP is secreted efficiently from infected cells (Feldmann et al., 2001).(<a href="#reference5282">Feldmann et al., 2001</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_244">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Viral capsid</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cytoplasm"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The assembly of new viral particles occurs on the inner surface of the plasma membrane, where VP24 and VP40 apparently associate both with new RNPs and with the cytoplasmic tail of GP2 (Bray and Paragas, 2002).(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_245">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Budding virus</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Cell_membrane"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
Nascent virions become enveloped by the GP-bearing lipid bilayer and exit the cell through budding (Bray and Paragas, 2002).  New data demonstrate the compartmentalization of Ebola and Marburg viral proteins in lipid rafts during viral assembly and budding (Bavari et al., 2002).(<a href="#reference5296">Bray et al., 2002</a>)(<a href="#reference5299">Bavari et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
  <bp:physicalEntityParticipant rdf:ID="bioobject_246">
    <bp:NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Virion</bp:NAME>
    <bp:CELLULAR-LOCATION rdf:resource="vocabulary_location_Extracellular"/>
    <bp:COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Function: .
The complete replication cycle takes approximately 12 hours.  As for many other viruses, filovirus replication triggers a cascade of reactions in infected cells, including the de novo production of type I interferon (IFN-/), which collectively constitute the innate antiviral response. At the same time, certain viral proteins apparently suppress some of these antiviral mechanisms, giving the virus an advantage over its host.  The ability of filoviruses to overcome initial defensive barriers and rapidly disseminate may be an essential factor in their virulence  (Bray and Paragas, 2002).(<a href="#reference5296">Bray et al., 2002</a>)</bp:COMMENT>
  </bp:physicalEntityParticipant>
